Brian J. Aneskievich
Professor/Pharmaceutical Science
Storrs Mansfield
Are you Brian J. Aneskievich?
How to update your information.
Grants
43 Grants
Deciphering the Role of TNIP1 Protein Conformational Flexibility in Suppressing Psoriasis-Associated Inflammatory Signaling
Sponsor: National Psoriasis Foundation
Authors: Brian J Aneskievich
2019-08-01 - 2020-07-31
Soluble Epidermal Growth Factor Receptor Isoforms: Functional Roles and Potential Therapeutic Application in Rheumatoid Arthritis
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
Funding: $5,000
2018-06-30 - 2019-06-30
Development of Small Molecules for Probing and Modulating TNIP1
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
2023-07-01 - 2025-06-30
A Novel Peroxisome Proliferator Activated Receptor (PPAR) Coregulator in Keratinocytes
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
Funding: $115,940
2002-09-09 - 2005-09-30
Keratinocyte Nuclear Receptor Coactivators
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
2014-04-01 - 2019-03-31
Enhancing Inflammation-Repressive Function of the Lupus Susceptibility Protein TNIP1
Sponsor: DOD/Department of Defense
Authors: Brian J Aneskievich
2025-07-01 - 2027-06-30
Functional Consequences and Expression Regulation of the Signal Repressor TNIP1
Sponsor: DHHS/NIH/National Institutes of Health
Authors: Brian J Aneskievich
2017-04-01 - 2022-03-31
Development and Assessment of a Sublingual Tablet Preparation of TRH to Enable New Therapeutic Applications
Sponsor: University of Connecticut Health Center
Authors: Brian J Aneskievich
Funding: $48,000
2013-07-01 - 2015-03-06
Mechanisms of Corepressor Recruitment by Nuclear Retinoid Receptors
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
Funding: $6,000
2008-09-01 - 2009-08-31
Nuclear Receptor Control of Human Epidermal Stem Cells
Sponsor: CT Department of Public Health/Connecticut Innovations
Authors: Brian J Aneskievich
Funding: $199,894
2010-06-01 - 2013-05-31
Keratinocyte Nuclear Receptor Coactivators
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
2002-05-01 - 2007-04-30
Drug-like Compound Identification and Development towards Novel Scleroderma Therapeutics
Sponsor: National Scleroderma Foundation
Authors: Brian J Aneskievich
2025-04-01 - 2027-03-31
Cytoplasmic Suppression of Inflammatory Signaling
Sponsor: DOD/Army/Army Medical Research Acquisition Activity
Authors: Brian J Aneskievich
Funding: $322,000
2020-07-01 - 2024-06-30
Mechanisms of Corepressor Recruitment by Nuclear Retinoid Receptors
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
Funding: $6,000
2007-09-01 - 2008-08-31
Keratinocyte Nuclear Receptor Coactivators
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
Funding: $1,421,070
2005-09-20 - 2012-07-31
Mechanisms of Corepressor Recruitment by Nuclear Retinoid Receptors.
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2006-09-01 - 2007-08-31
Keratinocyte Nuclear Receptor Coactivators
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
2005-05-01 - 2010-04-30
Control Over Keratinocyte Receptor Signaling Pathways by Psoriasis-Associated TNIP1
Sponsor: Pfizer
Authors: Brian J Aneskievich
Funding: $150,000
2015-11-06 - 2017-12-31
Small Molecule Regulators for a Key Repressor of IEC Inflammatory Signaling
Sponsor: Crohn's and Colitis Foundation of America
Authors: Brian J Aneskievich
2023-07-01 - 2026-06-30
Corepressor Control of Adipogenic PPARgamma
Sponsor: DHHS/NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Authors: Brian J Aneskievich
2006-04-01 - 2008-03-31